Patterns of prescribing hydroxyurea for sickle cell disease patients from a central hospital, Saudi Arabia.

Elghazaly, Assem A; Aljatham, Adel A; Khan, Abdulaziz M; Elneil, Rasha M; Jafar, S Zubair S; Elwishy, Salah A; Ahmed, Omsalma E; Bughnah, Aamer M; Ibrahim, Mamoun H

Elghazaly, Assem A; Aljatham, Adel A; Khan, Abdulaziz M; Elneil, Rasha M; Jafar, S Zubair S; Elwishy, Salah A; Ahmed, Omsalma E; Bughnah, Aamer M; Ibrahim, Mamoun H.

Afiliación

Elghazaly AA; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.
Aljatham AA; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.
Khan AM; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.
Elneil RM; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.
Jafar SZS; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.
Elwishy SA; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.
Ahmed OE; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.
Bughnah AM; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.
Ibrahim MH; Department of Adult Hematology Oncology, King Saud Medical City, Riyadh, Saudi Arabia.

Hematol Rep ; 11(1): 7860, 2019 Feb 19.

Article en En | MEDLINE | ID: mdl-30915204

Palabras clave

HU; Over- and under prescription; SCD

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hematol Rep Año: 2019 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google